No abstract available
MeSH terms
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Child
-
Cholesterol / blood*
-
Health Knowledge, Attitudes, Practice
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hyperlipoproteinemia Type II / complications
-
Hyperlipoproteinemia Type II / drug therapy
-
Hyperlipoproteinemia Type II / epidemiology
-
Mass Screening* / economics
-
Mass Screening* / ethics
-
National Heart, Lung, and Blood Institute (U.S.)
-
Patient Education as Topic
-
Practice Guidelines as Topic*
-
Primary Prevention
-
Risk
-
United States
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Cholesterol